Cryptosporidiosis

Primary Care Update for Ob/Gyns

Volumn 10, Issue 2, 2003, Pages 75-80

  Fahey, Trudi ^a,b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIDIARRHEAL AGENT; ATOVAQUONE; ATTAPULGITE; AZITHROMYCIN; BISMUTH SALICYLATE; CHLOROQUINE; DIPHENOXYLATE; KAOLIN; KAOLIN PECTIN; LOPERAMIDE; MEFLOQUINE; METRONIDAZOLE; MONOCLONAL ANTIBODY; OCTREOTIDE; OPIATE; PAROMOMYCIN; PECTIN; POLYCLONAL ANTIBODY; PYRIMETHAMINE; QUININE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL FEATURE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DEHYDRATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FECES ANALYSIS; GASTROINTESTINAL TRACT; HUMAN; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE TEST; INCUBATION TIME; INTESTINE CELL; MALABSORPTION; NONHUMAN; NUTRITIONAL DEFICIENCY; OOCYST; PARASITE TRANSMISSION; PREGNANCY; PRIORITY JOURNAL; STAINING; UNITED STATES;

EID: 0037335363     PISSN: 1068607X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1068-607X(02)00168-3     Document Type: Article

References (9)

1. Kirkpatrick B.D., Sears C.L. Cryptosporidiosis. Goldman L., Bennett C.J. Cecil textbook of medicine. 21st ed: 2000;1967-1969 W.B. Saunders, Philadelphia.
2. Goodgame R.W. Understanding intestinal spore-forming protozoa cryptosporidia, microsporidia, isospora, and cyclospora . Ann Intern Med. 124:1996;429-441.
3. Guerrant R.L. Cryptospridiosis an emerging, highly infectious threat . Emerg Infect Dis. 3:1997;51-57.
4. Mandell GL, Bennett JE, Dolin R. Cryptosporidium. In: Principles and practice of infectious diseases. 5th ed. Philadelphia: Churchill-Livingston; 2000:2903-14.
5. Kourtis A.P. Cryptosporidiosis. eMed J. 2:2001;1-11.
6. Sterling C.S. Cryptosporidiosis the treatment dilemma . J Med Microbiol. 49:2000;207-208.
7. Smith N.H., Cron S., Valdez L.M., et al. Combination drug therapy for cryptosporidiosis in AIDS. J Infect Dis. 178:1998;900-903.
8. Langer R.C., Riggs M.W. Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells. Infect Immunol. 67:1999;5282-5290.
9. 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Infect Diseases Obstet Gynecol. 8:2000;5-74.